JP2023519974A5 - - Google Patents
Info
- Publication number
- JP2023519974A5 JP2023519974A5 JP2022559578A JP2022559578A JP2023519974A5 JP 2023519974 A5 JP2023519974 A5 JP 2023519974A5 JP 2022559578 A JP2022559578 A JP 2022559578A JP 2022559578 A JP2022559578 A JP 2022559578A JP 2023519974 A5 JP2023519974 A5 JP 2023519974A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- formula
- conjugate
- integer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025096813A JP2025128284A (ja) | 2020-03-31 | 2025-06-10 | ｎｅｏＤｅｇｒａｄｅｒコンジュゲート |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003179P | 2020-03-31 | 2020-03-31 | |
| US63/003,179 | 2020-03-31 | ||
| US202063067967P | 2020-08-20 | 2020-08-20 | |
| US63/067,967 | 2020-08-20 | ||
| PCT/IB2021/052713 WO2021198965A1 (en) | 2020-03-31 | 2021-03-31 | Neodegrader conjugates |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025096813A Division JP2025128284A (ja) | 2020-03-31 | 2025-06-10 | ｎｅｏＤｅｇｒａｄｅｒコンジュゲート |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023519974A JP2023519974A (ja) | 2023-05-15 |
| JP2023519974A5 true JP2023519974A5 (OSRAM) | 2024-01-11 |
Family
ID=77928113
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559578A Pending JP2023519974A (ja) | 2020-03-31 | 2021-03-31 | ｎｅｏＤｅｇｒａｄｅｒコンジュゲート |
| JP2025096813A Pending JP2025128284A (ja) | 2020-03-31 | 2025-06-10 | ｎｅｏＤｅｇｒａｄｅｒコンジュゲート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025096813A Pending JP2025128284A (ja) | 2020-03-31 | 2025-06-10 | ｎｅｏＤｅｇｒａｄｅｒコンジュゲート |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230338564A1 (OSRAM) |
| EP (1) | EP4126067A4 (OSRAM) |
| JP (2) | JP2023519974A (OSRAM) |
| KR (1) | KR20230051120A (OSRAM) |
| CN (1) | CN115867322A (OSRAM) |
| AU (1) | AU2021249532A1 (OSRAM) |
| BR (1) | BR112022019532A2 (OSRAM) |
| CA (1) | CA3173118A1 (OSRAM) |
| IL (1) | IL296846A (OSRAM) |
| MX (1) | MX2022011825A (OSRAM) |
| WO (1) | WO2021198965A1 (OSRAM) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4041231A1 (en) * | 2019-10-09 | 2022-08-17 | Monte Rosa Therapeutics AG | Isoindolinone compounds |
| CA3213636A1 (en) | 2021-03-18 | 2022-09-22 | Seagen Inc. | Selective drug release from internalized conjugates of biologically active compounds |
| PE20250115A1 (es) * | 2021-06-03 | 2025-01-16 | Orum Therapeutics Inc | Conjugados de neodegradadores |
| TW202313022A (zh) * | 2021-06-03 | 2023-04-01 | 南韓商歐倫醫療公司 | 新降解劑－抗ｃｄ３３抗體綴合物 |
| CN119278201A (zh) * | 2022-03-09 | 2025-01-07 | 奥隆制药 | 效应t细胞的活化剂 |
| WO2023221975A1 (zh) | 2022-05-18 | 2023-11-23 | 苏州宜联生物医药有限公司 | 包含蛋白降解剂类生物活性化合物的抗体药物偶联物及其制备方法和用途 |
| CN115636811A (zh) * | 2022-08-17 | 2023-01-24 | 成都分迪药业有限公司 | 异吲哚啉苄胺衍生物的合成方法 |
| CA3268311A1 (en) * | 2022-10-06 | 2024-04-11 | Orum Therapeutics, Inc. | CONJUGATES OF NEO-DEGRADERS |
| CN118829637A (zh) | 2023-02-15 | 2024-10-22 | 石药集团巨石生物制药有限公司 | 一种度胺类分子胶衍生物及其用途 |
| WO2024187006A1 (en) * | 2023-03-08 | 2024-09-12 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Bioorthogonal activation of protac prodrugs |
| DK4601703T3 (da) | 2023-04-18 | 2026-05-11 | Astrazeneca Ab | Konjugater omfattende spaltelige linkere |
| CN119212734A (zh) | 2023-04-27 | 2024-12-27 | 石药集团巨石生物制药有限公司 | 一种抗体药物偶联物 |
| WO2024222841A1 (zh) * | 2023-04-27 | 2024-10-31 | 石药集团巨石生物制药有限公司 | 一种抗体药物偶联物 |
| WO2024238872A2 (en) * | 2023-05-18 | 2024-11-21 | Firefly Bio, Inc. | Isoindolinone-glutarimide antibody conjugates, and uses thereof |
| EP4512427A1 (en) * | 2023-08-25 | 2025-02-26 | Mablink Bioscience | Antibody-drug conjugates based on molecular glue degraders and uses thereof |
| WO2025168071A1 (zh) * | 2024-02-08 | 2025-08-14 | 映恩生物制药（苏州）有限公司 | 一种含氮杂环化合物、其偶联物及其制备方法和用途 |
| WO2025252247A1 (zh) * | 2024-06-07 | 2025-12-11 | 上海齐鲁制药研究中心有限公司 | Gspt1降解剂抗体偶联物 |
| WO2026007898A1 (zh) * | 2024-07-01 | 2026-01-08 | 上海海雁医药科技有限公司 | 含苯乙氧基亚烷基胺结构的异吲哚啉化合物、其药物组合物及应用 |
| WO2026032417A1 (zh) * | 2024-08-08 | 2026-02-12 | 石药集团巨石生物制药有限公司 | Gspt1降解剂和含有gspt1降解剂的抗体偶联物及其用途 |
| WO2026041050A1 (zh) * | 2024-08-20 | 2026-02-26 | 海思科医药集团股份有限公司 | 一种配体-蛋白降解剂偶联物及其在医药上的应用 |
| WO2026077418A1 (zh) * | 2024-10-11 | 2026-04-16 | 上海海雁医药科技有限公司 | 含苯乙氧基亚烷基胺结构的异吲哚啉化合物及其偶联物和用途 |
| WO2026092541A1 (zh) * | 2024-10-29 | 2026-05-07 | 苏州宜联生物医药有限公司 | 一种包含蛋白降解剂的药物连接体偶联物及其制备方法和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030045552A1 (en) * | 2000-12-27 | 2003-03-06 | Robarge Michael J. | Isoindole-imide compounds, compositions, and uses thereof |
| US8877780B2 (en) * | 2006-08-30 | 2014-11-04 | Celgene Corporation | 5-substituted isoindoline compounds |
| EP2358697B1 (en) * | 2008-10-29 | 2015-10-21 | Celgene Corporation | Isoindoline compounds for use in the treatment of cancer. |
| US8114621B2 (en) * | 2010-03-12 | 2012-02-14 | Saladax Biomedical Inc. | Lenalidomide and thalidomide immunoassays |
| EP3160486B1 (en) * | 2014-06-27 | 2020-11-18 | Celgene Corporation | Compositions and methods for inducing conformational changes in cereblon other e3 ubiquitin ligases |
| US9499514B2 (en) * | 2014-07-11 | 2016-11-22 | Celgene Corporation | Antiproliferative compounds and methods of use thereof |
| CA2969908A1 (en) * | 2014-12-09 | 2016-06-16 | Abbvie Inc. | Antibody drug conjugates with cell permeable bcl-xl inhibitors |
| AR113224A1 (es) * | 2017-04-28 | 2020-02-19 | Novartis Ag | Conjugados de anticuerpo que comprenden un agonista de sting |
| US12172986B2 (en) * | 2018-06-01 | 2024-12-24 | Eisai R&D Management Co., Ltd | Splicing modulator antibody-drug conjugates and methods of use |
-
2021
- 2021-03-31 CN CN202180025882.5A patent/CN115867322A/zh active Pending
- 2021-03-31 WO PCT/IB2021/052713 patent/WO2021198965A1/en not_active Ceased
- 2021-03-31 EP EP21779309.0A patent/EP4126067A4/en active Pending
- 2021-03-31 JP JP2022559578A patent/JP2023519974A/ja active Pending
- 2021-03-31 MX MX2022011825A patent/MX2022011825A/es unknown
- 2021-03-31 CA CA3173118A patent/CA3173118A1/en active Pending
- 2021-03-31 AU AU2021249532A patent/AU2021249532A1/en active Pending
- 2021-03-31 US US17/995,006 patent/US20230338564A1/en active Pending
- 2021-03-31 KR KR1020227037931A patent/KR20230051120A/ko active Pending
- 2021-03-31 BR BR112022019532A patent/BR112022019532A2/pt unknown
- 2021-03-31 IL IL296846A patent/IL296846A/en unknown
-
2025
- 2025-06-10 JP JP2025096813A patent/JP2025128284A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024533309A5 (OSRAM) | ||
| JP7630190B2 (ja) | Ｃｄ７を標的にするヒト化抗体及びその使用 | |
| JP2022511813A5 (OSRAM) | ||
| US20230242877A1 (en) | Immune cell comprising chimeric antigen receptor and use thereof | |
| JP7590034B2 (ja) | Ｎｋｇ２ａを標的にする抗体及びその使用 | |
| JP2019523630A5 (OSRAM) | ||
| JP2021523192A5 (OSRAM) | ||
| JP2022548796A5 (OSRAM) | ||
| WO2018121605A1 (zh) | 一种多功能蛋白质 | |
| FI4034252T3 (fi) | Saranadomeenin sisältäviä Notch-reseptoreita | |
| RU2016151721A (ru) | Триспецифичные связывающие молекулы, которые специфически связывают антигены множества злокачественных опухолей, и способы их применения | |
| JP2019502746A5 (OSRAM) | ||
| JP2023527530A (ja) | 同種異系移植のための操作された免疫細胞 | |
| JPH02501800A (ja) | 組換ｄｎａ産物及び方法 | |
| JP2025128284A (ja) | ｎｅｏＤｅｇｒａｄｅｒコンジュゲート | |
| JP2021534769A5 (OSRAM) | ||
| JP2023546725A5 (OSRAM) | ||
| JP2023513156A5 (OSRAM) | ||
| JP2023550148A5 (OSRAM) | ||
| CN115698088A (zh) | 免疫细胞衔接器多特异性结合蛋白及其制备和应用 | |
| JP2021505637A5 (OSRAM) | ||
| WO2023207390A1 (zh) | 一种ciita基因被敲除的工程化免疫细胞及其用途 | |
| WO2023207388A1 (zh) | 一种cd7基因被敲除的工程化免疫细胞及其用途 | |
| JP2024511423A5 (OSRAM) | ||
| JP2025503513A5 (OSRAM) |